Skip to main content
DNA Labs India

Oncomine Comprehensive Plus Panel Test

DNA Labs India | ISO 9001:2015 Certified

Oncomine Comprehensive Plus Panel Test

Also known as: Comprehensive Cancer Genetic Panel, Oncomine Plus Panel, Cancer Genomic Profiling Test

Oncomine Comprehensive Plus Panel Test test available at DNA Labs India for ₹195,000. Uses Next-Generation Sequencing (NGS) on Tumor tissue samples. Results in 2-3 weeks. Free home collection in 300+ cities across India.

Genetic Panel TestAdults🏠 Home Collection

🩺 Medically Reviewed By

Overview

The purpose of the Oncomine Comprehensive Plus Panel is to provide detailed genetic profiling of cancer tumors to inform treatment strategies. It helps identify mutations that may respond to specific drugs, assess prognosis, and determine eligibility for clinical trials, thereby supporting personalized medicine in oncology.

Test Code
3129
Price
₹195,000
Sample Type
Tumor tissue
Result Time
2-3 weeks
Fasting Required
No
Method
Next-Generation Sequencing (NGS)
Step 1

Sample Collection

Ensure a doctor's prescription is available. Inform the lab of any relevant medical history or treatments.

Method: Biopsy or Surgical Specimen

Step 2

Laboratory Analysis

Sample collection involves obtaining tumor tissue via biopsy or surgical procedure, performed by a qualified healthcare professional.

Step 3

Report Delivery

Sample is preserved and sent to the lab for processing. Follow any post-procedure care instructions from your doctor.

Timeline: 2-3 weeks

Patient Instructions

1
Before the Test:Obtain a doctor's prescription and discuss the test's purpose and implications.
2
During the Test:Sample collection is performed via biopsy or surgery; the process is minimally invasive depending on the procedure.
3
After the Test:Results are available in 2-3 weeks; follow up with your doctor for interpretation and next steps.

About This Test

Who Should Get This Test

The purpose of the Oncomine Comprehensive Plus Panel is to provide detailed genetic profiling of cancer tumors to inform treatment strategies. It helps identify mutations that may respond to specific drugs, assess prognosis, and determine eligibility for clinical trials, thereby supporting personalized medicine in oncology.

How to Prepare

  • Obtain tumor tissue sample through biopsy or surgery
  • Use appropriate containers and preservation methods
  • Label samples correctly with patient details
  • Transport samples at ambient temperature unless specified

Doctor's Notes

Reviewed by — MBBS, MD (Medical Genetics) · Reg. No. 8532

"This comprehensive genetic panel is essential for identifying targeted treatment options and improving outcomes in cancer patients."

Last medically reviewed: September 7, 2026

Test Parameters & Specifications

Sample TypeTumor tissue
Collection MethodBiopsy or Surgical Specimen

Sample Stability

Tumor tissue samples are stable at ambient temperature for up to 48 hours
For longer storage, samples should be refrigerated or frozen as per lab guidelines
Sample Rejection Criteria:
  • Insufficient sample volume or quality
  • Improper labeling or documentation
  • Sample contamination or degradation
  • Lack of valid doctor's prescription where required

Understanding Your Results

Results from the Oncomine Comprehensive Plus Panel provide insights into genetic mutations and signatures in cancer tumors. Interpretation should be done by a qualified healthcare professional in the context of the patient's clinical history.
Pathogenic variants indicate mutations associated with cancer and may guide treatment
Benign variants are generally not clinically significant
Variants of uncertain significance (VUS) require further evaluation
Genomic signatures may indicate tumor characteristics like microsatellite instability
Consult with an oncologist or genetic counselor for personalized advice
⚠️ When to Consult a Doctor:

Consult your doctor immediately if results show pathogenic variants or if you have questions about treatment options. Regular follow-up is recommended based on findings.

Limitations

  • May not detect all genetic variants due to technical constraints
  • Results are dependent on tumor cellularity and sample adequacy
  • Does not replace standard diagnostic methods like histopathology
  • Interpretation requires clinical correlation by a healthcare professional

Risks & Considerations

  • Minimal risks associated with biopsy or surgical sample collection, such as infection or bleeding
  • Psychological impact of genetic results; counseling may be recommended

Interfering Factors

  • Poor sample quality or insufficient tumor tissue
  • Contamination during sample collection or processing
  • Previous treatments affecting DNA integrity
  • Technical limitations of NGS technology

Compare With Similar Tests

TestOncomine Comprehensive Plus PanelFoundationOne CDxGuardant360MSK-IMPACTTempus xT
ComparisonOncomine Comprehensive Plus Panel

Frequently Asked Questions

What is the Oncomine Comprehensive Plus Panel?
It is a genetic test that analyzes 161 genes and 4 genomic signatures associated with cancer to guide treatment decisions.
How is the test performed?
The test uses Next-Generation Sequencing (NGS) on tumor tissue samples obtained via biopsy or surgery.
What sample is required for this test?
Tumor tissue samples, such as from biopsies or surgical specimens, are required.
How long does it take to get results?
Results are typically available within 2-3 weeks after sample receipt.
Is the test covered by insurance?
Coverage varies; it is not typically covered by standard insurance schemes in India. Check with your provider.
What are the benefits of this test?
It helps identify targeted therapies, assess prognosis, and determine eligibility for clinical trials, enabling personalized cancer treatment.
Are there any risks associated with the test?
Risks are minimal and related to sample collection procedures, such as biopsy-related complications.
How accurate is the Oncomine Comprehensive Plus Panel?
The test is highly accurate due to advanced NGS technology, but results should be interpreted clinically.
Can the test be done at home?
No, sample collection requires a medical procedure, but DNA Labs India offers home collection for the sample transport.
What if the results are abnormal?
Abnormal results indicate genetic mutations; consult your oncologist for treatment options and further management.
How does this test differ from other genetic tests?
It is a comprehensive panel covering many genes and signatures, unlike targeted tests that focus on specific genes.
Who should take this test?
Patients with diagnosed cancer, especially for treatment planning, recurrent disease, or family history of cancer.
Worried about the process? Our certified phlebotomists collect thousands of samples every month across India. The process takes under 5 minutes and is virtually painless. Questions? Message us on WhatsApp — we're here 7 days a week.

Related Tests

For Hospitals & Clinics

Reference Laboratory Services

We serve as a reference laboratory for hospitals and clinics across India. Send samples from your facility with same-day pickup, priority processing, and results delivered through our online portal. Competitive institutional pricing available.

LIMS Integration

Your Data Privacy

Your medical data is protected under Indian law.

Stored in India: All patient records are stored on servers located in India. No data is transferred outside the country.

DPDP Act Compliant: Under the Digital Personal Data Protection Act 2023, you can request deletion of your records at any time by contacting support.

Book Your Test

Enter your details and we'll connect you within 15 minutes.

🧬

Quick Connect

Enter your mobile number and we’ll connect you with the team.

+91

✅ Connecting you now...

🔒 Your number is used to respond to this request.